Rupinta, Edelyn Faye T.
HRN: 17-33-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5 Gm
Q 8h
S/P Repeat LTCS W/ BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes